A carregar...
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
The last several years have witnessed exciting progress in the development of immunotherapy for the treatment of cancer. This has been due in great part to the development of so-called checkpoint blockade. That is, antibodies that block inhibitory receptors such as CTLA-4 and PD-1 and thus unleash a...
Na minha lista:
| Publicado no: | Comput Struct Biotechnol J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Research Network of Computational and Structural Biotechnology
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4415113/ https://ncbi.nlm.nih.gov/pubmed/25941561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.csbj.2015.03.008 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|